Automation, decentralized manufacturing, and supportive regulations are helping to surmount technical difficulties in cell and gene therapy manufacturing.

The administration is trying to balance the president's commitment to the policy with the country's economic realities.

Shareholder/Analyst Call June 18, 2026 10:00 AM EDTCompany ParticipantsRobert Bailhache - Director and Head of ...

AWS's flagship East Coast developer conference opens tomorrow, June 17, at the Jacob K. Javits Convention Center in Manhattan — and the in-person registration window has already closed at maximum ...

For the past 30 years, Huawei has provided innovative products and solutions to ensure the secure and stable operations of our customers' networks no matter what comes their way, be it earthquakes, ...

Google's open-source diffusion language model generates 256 tokens in parallel and self-corrects, hitting 4x speed on one GPU ...

Hermes Gehnen was born in China, and not in Germany, as originally stated. When 20-year-old Hermes Gehnen set up his company N25 Caviar in 2017, he had a lot of convincing to do. He was sourcing ...

Global weather extremes, from monsoons to droughts, are shaped by a network of recurrent, coupled ocean–atmosphere patterns known as climate modes. These modes, spanning from the Pacific’s El ...